118 related articles for article (PubMed ID: 4027952)
1. Photocytotoxicity in vivo of haematoporphyrin derivative components.
Cowled PA; Forbes IJ
Cancer Lett; 1985 Aug; 28(1):111-8. PubMed ID: 4027952
[TBL] [Abstract][Full Text] [Related]
2. meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity.
Berenbaum MC; Akande SL; Bonnett R; Kaur H; Ioannou S; White RD; Winfield UJ
Br J Cancer; 1986 Nov; 54(5):717-25. PubMed ID: 2948536
[TBL] [Abstract][Full Text] [Related]
3. In vivo biological activity of the components of haematoporphyrin derivative.
Berenbaum MC; Bonnett R; Scourides PA
Br J Cancer; 1982 Apr; 45(4):571-81. PubMed ID: 6462161
[TBL] [Abstract][Full Text] [Related]
4. Influence of a haematoporphyrin derivative on the protoporphyrin IX synthesis and photodynamic effect after 5-aminolaevulinic acid sensitization in human colon carcinoma cells.
Messmann H; Geisler M; Gross U; Abels C; Szeimies RM; Steinbach P; Knüchel R; Doss M; Schölmerich J; Holstege A
Br J Cancer; 1997; 76(7):878-83. PubMed ID: 9328146
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of photodynamic therapy with haematoporphyrin derivatives by glucocorticoids.
Cowled PA; Mackenzie L; Forbes IJ
Cancer Lett; 1985 Oct; 29(1):107-14. PubMed ID: 3904976
[TBL] [Abstract][Full Text] [Related]
6. Phototherapy of human tumours using haematoporphyrin derivative.
Forbes IJ; Cowled PA; Leong AS; Ward AD; Black RB; Blake AJ; Jacka FJ
Med J Aust; 1980 Nov; 2(9):489-93. PubMed ID: 7207345
[TBL] [Abstract][Full Text] [Related]
7. Variation in the fluorescence decay properties of haematoporphyrin derivative during its conversion to photoproducts.
König K; Wabnitz H; Dietel W
J Photochem Photobiol B; 1990 Dec; 8(1):103-11. PubMed ID: 2127429
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy of C3H mouse mammary carcinoma with haematoporphyrin di-ethers as sensitizers.
Evensen JF; Sommer S; Rimington C; Moan J
Br J Cancer; 1987 May; 55(5):483-6. PubMed ID: 2955805
[TBL] [Abstract][Full Text] [Related]
9. Comparison of fluorescence and photodynamic activities of whole hematoporphyrin derivative and its enriched active components.
Nelson JS; Wright WH; Berns MW
J Natl Cancer Inst; 1985 Dec; 75(6):1135-40. PubMed ID: 2933546
[TBL] [Abstract][Full Text] [Related]
10. Modification by vasoactive drugs of tumour destruction by photodynamic therapy with haematoporphyrin derivative.
Cowled PA; Forbes IJ
Br J Cancer; 1989 Jun; 59(6):904-9. PubMed ID: 2525402
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of pulsed and continuous-wave red laser light in induction of photocytotoxicity by haematoporphyrin derivative.
Cowled PA; Grace JR; Forbes IJ
Photochem Photobiol; 1984 Jan; 39(1):115-7. PubMed ID: 6230683
[No Abstract] [Full Text] [Related]
12. Development of a topical hematoporphyrin derivative formulation: characterization of photosensitizing effects in vivo.
McCullough JL; Weinstein GD; Lemus LL; Rampone W; Jenkins JJ
J Invest Dermatol; 1983 Dec; 81(6):528-32. PubMed ID: 6227672
[TBL] [Abstract][Full Text] [Related]
13. A modelling approach to the detection of subcutaneous tumours by haematoporphyrin-derivative fluorescence.
van der Putten WJ; van Gemert MJ
Phys Med Biol; 1983 Jun; 28(6):639-45. PubMed ID: 6224222
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of 28 porphyrins and their abilities to localize in mammary mouse carcinoma: uroporphyrin I superior to hematoporphyrin derivative.
El-Far M; Pimstone N
Prog Clin Biol Res; 1984; 170():661-72. PubMed ID: 6241706
[TBL] [Abstract][Full Text] [Related]
15. Picosecond fluorescence of R3230AC mammary carcinoma mitochondria after treatment with hematoporphyrin derivative and Photofrin II in vivo.
Hanzlik CA; Knox RS; Gibson SL; Hilf R
Photochem Photobiol; 1989 Jul; 50(1):45-53. PubMed ID: 2527374
[TBL] [Abstract][Full Text] [Related]
16. Treatment of mouse carcinomas with intratumoral injections of hematoporphyrin derivative and red light.
Moseng D; Volden G; Midelfart K; Kavli G; Christensen T; Moan J
Photodermatol; 1985 Apr; 2(2):107-10. PubMed ID: 4034416
[TBL] [Abstract][Full Text] [Related]
17. The effect of photodynamic therapy on a retinoblastoma-like tumour. An experimental in vitro and in vivo study on the potential use of photodynamic therapy in the treatment of retinoblastoma.
Winther JB
Acta Ophthalmol Suppl (1985); 1990; (197):1-37. PubMed ID: 2176429
[TBL] [Abstract][Full Text] [Related]
18. Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrin derivative.
van Gemert JC; Berenbaum MC; Gijsbers GH
Br J Cancer; 1985 Jul; 52(1):43-9. PubMed ID: 3160379
[TBL] [Abstract][Full Text] [Related]
19. Detection of early lung cancer using low dose Photofrin II.
Lam S; Palcic B; McLean D; Hung J; Korbelik M; Profio AE
Chest; 1990 Feb; 97(2):333-7. PubMed ID: 2137075
[TBL] [Abstract][Full Text] [Related]
20. The combined effect of haematoporphyrin derivative and light on the normal mouse retina.
Winther J; Ehlers N
Acta Ophthalmol (Copenh); 1984 Feb; 62(1):112-22. PubMed ID: 6720265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
